PIH responds to the World Health Organization's Global Tuberculosis Report 2015

endTB is an innovative project using new TB drugs implemented by the international organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD), and funded by UNITAID with a four-year, 60.4 million USD grant. This poject aims to produce concrete results in the form of more effective and better-tolerated regimens for MDR-TB that will in turn lead to greater access.

A new study confirms PIH's success rates in Lesotho are among the world's best for multidrug-resistant tuberculosis.

While taking a social medicine course in Uganda, students call on governments to renew funding for fight against AIDS, tuberculosis, and malaria.

An op-ed from the Huffington Post published on World TB Day.

A patient in Malawi struggles to overcome poverty, access to health care, and tuberculosis.

On World Tuberculosis Day, a new website shares the stories of children facing a deadly but curable disease.

In Russia, PIH and the local government diagnose TB patients faster with GeneXpert machine.

An expert panel to discuss managing second line drugs for multidrug-resistant tuberculosis, February 20-24.

Global Post reporter John Donnelly shows how a PIH nurse in Peru saved the life of a woman living with multidrug-resistant tuberculosis.